ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,307.01
-0.27%
Dow Jones
39,671.04
-0.51%
US Dollar vs MXN
16.6664
0.01%
Brent Oil
81.165
-0.45%
Bitcoin
69,358.96
0.37%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. PRA Health Sciences Inc (PRAH)

  7. PRA Health Sciences Inc (PRAH) Noticias

PRAH

PRA Health Sciences (PRAH)

PRA Health Sciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PRAH
FechaHoraFuenteTítuloSímboloCompañía
02/02/202211:50Edgar (US Regulatory)Schedule 13gNASDAQ:PRAHPRA Health Sciences Inc
13/07/202105:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PRAHPRA Health Sciences Inc
12/07/202115:27Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRAHPRA Health Sciences Inc
12/07/202109:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRAHPRA Health Sciences Inc
01/07/202117:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRAHPRA Health Sciences Inc
01/07/202108:49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRAHPRA Health Sciences Inc
01/07/202108:39Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:PRAHPRA Health Sciences Inc
01/07/202107:57Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRAHPRA Health Sciences Inc
30/06/202111:28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:PRAHPRA Health Sciences Inc
28/06/202117:07PR Newswire (US)DT Midstream Set to Join S&P MidCap 400NASDAQ:PRAHPRA Health Sciences Inc
23/06/202107:01Business WireVeradigm and PRA Health Sciences Partner to Create the Industry’s Leading EHR-Based Clinical Research NetworkNASDAQ:PRAHPRA Health Sciences Inc
14/06/202108:28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PRAHPRA Health Sciences Inc
26/05/202106:00GlobeNewswire Inc.Anavex Life Sciences Announces Appointment of Ms Jiong Ma, PhD to Board of DirectorsNASDAQ:PRAHPRA Health Sciences Inc
13/05/202115:02GlobeNewswire Inc.PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with SynomaNASDAQ:PRAHPRA Health Sciences Inc
28/04/202115:01GlobeNewswire Inc.PRA Health Sciences, Inc. Reports First Quarter 2021 ResultsNASDAQ:PRAHPRA Health Sciences Inc
28/04/202105:07Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:PRAHPRA Health Sciences Inc
21/04/202115:02GlobeNewswire Inc.PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutic...NASDAQ:PRAHPRA Health Sciences Inc
13/04/202115:02GlobeNewswire Inc.PRA Health Sciences selected by Maryland State Medical Society to supply remote patient monitoring and telehealth servicesNASDAQ:PRAHPRA Health Sciences Inc
07/04/202115:01GlobeNewswire Inc.PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human g...NASDAQ:PRAHPRA Health Sciences Inc
30/03/202116:20Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PRAHPRA Health Sciences Inc
22/03/202115:01GlobeNewswire Inc.PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical ProgramsNASDAQ:PRAHPRA Health Sciences Inc
25/02/202106:11TipRanksPRA Health Sciences To Be Acquired By ICON For $12B; Shares Pop 19%NASDAQ:PRAHPRA Health Sciences Inc
24/02/202110:59Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PRAHPRA Health Sciences Inc
24/02/202105:04GlobeNewswire Inc.PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2020 ResultsNASDAQ:PRAHPRA Health Sciences Inc
24/02/202105:00Business WireICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical ResearchNASDAQ:PRAHPRA Health Sciences Inc
04/02/202112:00GlobeNewswire Inc.PRA Health Sciences to Report Fourth Quarter and Full Year 2020 EarningsNASDAQ:PRAHPRA Health Sciences Inc
17/12/202015:02GlobeNewswire Inc.PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilitiesNASDAQ:PRAHPRA Health Sciences Inc
19/11/202015:02GlobeNewswire Inc.PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Str...NASDAQ:PRAHPRA Health Sciences Inc
05/11/202012:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PRAHPRA Health Sciences Inc
04/11/202015:01GlobeNewswire Inc.PRA Health Sciences, Inc. Reports Third Quarter 2020 Results and Updates Full Year 2020 GuidanceNASDAQ:PRAHPRA Health Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:PRAH

Su Consulta Reciente

NYSE
DIS
Walt Disney
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
MCD
McDonalds
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
GOOGL
Alphabet
FX
USDMXN
US Dollar vs MXN
NASDAQ
NVDA
NVIDIA
NYSE
JPM
JP Morgan Chase
COIN
ETHUSD
Ethereum
USOTC
ADDYY
Adidas (QX)
CCOM
OILBRENT
Brent Oil
NYSE
BAC
Bank of America
COIN
BTCUSD
Bitcoin
USOTC
RHHBY
Roche (QX)
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados